Staywell Formulation Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2007.
2007 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Staywell Formulation Private Limited

Staywell Formulation Private Limited, a active private limited company, was established on 20 November 2007 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233DL2007PTC170595. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.84 Cr.

It upholds a compliant status. Employing 32 professional, Its leadership includes Suresh Lal Santuka (Director), Vikash Kumar Santuka (Director). Past directors included Surendra Singh Pokhariyal, Sidharatha Bansal, Ruchi Tyagi. It holds ₹11.80 Cr open charges and ₹6.60 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at First Floor, 14, Rani Jhansi Road, New Delhi, Delhi, 110055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233DL2007PTC170595

  • Registration Number

    170595

  • Incorporation Date

    20 November 2007

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹2.84 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 2.84 Cr
  • Company Age 18 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 11.80 Cr
  • Satisfied Charges ₹ 6.60 Cr
  • Revenue Growth **** 22.24%
  • Profit Growth **** -2810.17%
  • Ebitda **** -65.02%
  • Net Worth -19.25%
  • Total Assets -10.10%
Company report

Staywell Formulation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Staywell Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Staywell Formulation Private Limited?
Current Directors
Name Designation Appointment Date Status
Suresh Lal Santuka Director 21 Dec 2015 Current
Vikash Kumar Santuka Director 21 Dec 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jun 2023 Past
Pramod Abcsdd Director 30 Sep 2011 Past
Pramod Abcsdd Director 06 Jun 2023 Past
Pramod Abcsdd Director 31 Mar 2019 Past
Pramod Abcsdd Director 20 Aug 2013 Past
Pramod Abcsdd Director 25 Oct 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Staywell Formulation.

Staywell Formulation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.24% increase. The company also saw a substantial fall in profitability, with a 2810.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.25%.

Staywell Formulation revenue growth over time
Staywell Formulation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 22.24%
*******
*******
*******
*******
Revenue from Operations
*******
 21.98%
*******
*******
*******
*******
Total Assets
*******
 -10.10%
*******
*******
*******
*******
Profit or Loss
*******
 -2810.17%
*******
*******
*******
*******
Net Worth
*******
 -19.25%
*******
*******
*******
*******
EBITDA
*******
 -65.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Staywell Formulation?

Unlock access to Staywell Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹118,036,000.00

Satisfied Charges

₹66,000,000.00

Charges Breakdown by Lending Institutions
  • Dena Bank : 11.80 Cr
Latest Charge Details
Date Lender Amount Status
19 Mar 2012 Dena Bank ₹11.80 Cr Open
27 Mar 2010 Canara Bank ₹8.00 M Satisfied
30 Mar 2009 Canara Bank ₹5.00 M Satisfied
30 Mar 2009 Canara Bank ₹3.30 Cr Satisfied
30 Mar 2009 Canara Bank ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Staywell Formulation?

Staywell Formulation has a workforce of 32 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Staywell Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Staywell Formulation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Staywell Formulation
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Staywell Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Staywell Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Suresh Lal Santuka was appointed as a Director was appointed as a Director on 21 Dec 2015 & has been associated with this company since 10 years 1 month . was documented.

  • Director Appointment

    Vikash Kumar Santuka was appointed as a Director was appointed as a Director on 21 Dec 2015 & has been associated with this company since 10 years 1 month . was recorded as a recent event.

  • Charges

    The activity A charge with Dena Bank of Rs. 11.80 Cr registered on 19 Mar 2012 with Charge ID 10347346 was modified on 30 Dec 2014. was completed.

  • Charges

    The activity A charge registered on 27 Mar 2010 via Charge ID 10220401 with Canara Bank was fully satisfied on 22 Apr 2013. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Staywell Formulation Private Limited?

The CIN of Staywell Formulation Private Limited is U24233DL2007PTC170595.

Where is Staywell Formulation Private Limited headquartered?

Staywell Formulation Private Limited is headquartered at First Floor, 14, Rani Jhansi Road, New Delhi, Delhi, 110055.

When was Staywell Formulation Private Limited incorporated?

Staywell Formulation Private Limited was incorporated on 20 November 2007.

Who are the current directors of Staywell Formulation Private Limited?

The current directors of Staywell Formulation Private Limited are

What is the primary industry of Staywell Formulation Private Limited?

The primary industry of Staywell Formulation Private Limited is Manufacturing.

Is Staywell Formulation Private Limited a listed company?

Staywell Formulation Private Limited is unlisted.

What is the capital structure of Staywell Formulation Private Limited?

The authorized capital of Staywell Formulation Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.84 Cr.

What is the compliance status of Staywell Formulation Private Limited?

The compliance status of Staywell Formulation Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available